Literature DB >> 20354743

Quantitative trait locus on chromosome X affects bone loss after maturation in mice.

Shuzo Okudaira1, Motoyuki Shimizu, Bungo Otsuki, Rika Nakanishi, Akira Ohta, Keiichi Higuchi, Masanori Hosokawa, Tadao Tsuboyama, Takashi Nakamura.   

Abstract

Genetic programming is known to affect the peak bone mass and bone loss after maturation. However, little is known about how polymorphic genes on chromosome X (Chr X) modulate bone loss after maturation. We previously reported a quantitative trait locus (QTL) on Chr X, designated Pbd3, which had a suggestive linkage to bone mass, in male SAMP2 and SAMP6 mice. In this study, we aimed to clarify the effects of Pbd3 on the skeletal phenotype. We generated a congenic strain, P2.P6-X, carrying a 45.6-cM SAMP6-derived Chr X interval on a SAMP2 genetic background. The effects of Pbd3 on the bone phenotype were determined by microcomputed tomography (microCT), whole-body dual-energy X-ray absorptiometry (DXA), serum bone turnover markers, and histomorphometric parameters. Both the bone area fraction (BA/TA) on microCT and whole-body DXA revealed reduced bone loss in P2.P6-X compared with that in SAMP2. The serum concentrations of bone turnover markers at 4 months of age were significantly lower in P2.P6-X than in SAMP2, but did not differ at 8 months of age. These results were observed in female mice, but not in male mice. In conclusion, a QTL within a segregated 45.6-cM interval on Chr X is sex-specifically related to the rate of bone loss after maturation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354743     DOI: 10.1007/s00774-010-0168-1

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  69 in total

1.  A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.

Authors:  Aya Sasaki; Yoshiko Masuda; Kazuhiro Iwai; Kyoji Ikeda; Ken Watanabe
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

2.  The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage.

Authors:  R S Weinstein; R L Jilka; A M Parfitt; S C Manolagas
Journal:  Endocrinology       Date:  1997-09       Impact factor: 4.736

3.  Sex- and age-related response to aromatase deficiency in bone.

Authors:  C Miyaura; K Toda; M Inada; T Ohshiba; C Matsumoto; T Okada; M Ito; Y Shizuta; A Ito
Journal:  Biochem Biophys Res Commun       Date:  2001-02-02       Impact factor: 3.575

4.  Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice.

Authors:  Rika Nakanishi; Motoyuki Shimizu; Masayuki Mori; Haruhiko Akiyama; Shuzo Okudaira; Bungo Otsuki; Maiko Hashimoto; Keiichi Higuchi; Masanori Hosokawa; Tadao Tsuboyama; Takashi Nakamura
Journal:  J Bone Miner Res       Date:  2006-11       Impact factor: 6.741

5.  Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.

Authors:  Riko Kitazawa; Sohei Kitazawa
Journal:  Mol Endocrinol       Date:  2006-09-28

6.  Receptor activator of NF-kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4.

Authors:  Wei Liu; Shunqing Wang; Shi Wei; Li Sun; Xu Feng
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

7.  Bone has a sexually dimorphic response to aromatase deficiency.

Authors:  O K Oz; J E Zerwekh; C Fisher; K Graves; L Nanu; R Millsaps; E R Simpson
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

8.  Bone mass increase specific to the female in a line of transgenic mice overexpressing human osteoblast stimulating factor-1.

Authors:  Tamotsu Hashimoto-Gotoh; Hideo Ohnishi; Atsushi Tsujimura; Hiroaki Tsunezuka; Kan Imai; Haruchika Masuda; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

9.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

10.  In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.

Authors:  Peng Xiao; Yuan Chen; Hui Jiang; Yao-Zhong Liu; Feng Pan; Tie-Lin Yang; Zi-Hui Tang; Jennifer A Larsen; Joan M Lappe; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

View more
  2 in total

Review 1.  Morphological and molecular characterization of the senile osteoporosis in senescence-accelerated mouse prone 6 (SAMP6).

Authors:  Kagaku Azuma; Qian Zhou; Kin-Ya Kubo
Journal:  Med Mol Morphol       Date:  2018-04-04       Impact factor: 2.309

Review 2.  Characterization of senescence-accelerated mouse prone 6 (SAMP6) as an animal model for brain research.

Authors:  Kimie Niimi; Eiki Takahashi
Journal:  Exp Anim       Date:  2014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.